QXO, Inc. (QXO) Balance Sheet

The balance sheet has undergone a dramatic expansion, with total assets multiplying over a thousand-fold in just over two years. This growth is almost entirely inorganic, as evidenced by the jump in goodwill from $1.1M to $6.2B, reflecting the company's aggressive M&A strategy. While the asset base now rivals established distributors, the negative retained earnings of -$761M indicate that the company is yet to generate cumulative profits from its new operations, suggesting that the balance sheet strength is built on capital infusions rather than organic earnings.

The company's leverage profile has been volatile, with debt levels spiking to $4.1B in mid-2025 before being reduced to $1.0B by 2026Q2. This pattern suggests that debt was used as a bridge to finance acquisitions, likely followed by equity raises or cash flow to pay down the debt. The current D/E of 0.10 is low compared to peers like IBP (1.48) and BLDR (1.30), indicating a strong balance sheet buffer. However, the rapid swings in debt levels highlight the company's reliance on external financing for its roll-up strategy, and investors should monitor whether future acquisitions will require additional debt, potentially increasing leverage.

The asset mix has shifted dramatically, with goodwill and intangibles now dominating the balance sheet. This is typical of a roll-up strategy, but it also means that a significant portion of the company's assets are not tangible and are subject to impairment testing. The relatively low PPE of $1.6B suggests that the company is not investing heavily in physical infrastructure, which aligns with its tech-enabled distribution model. However, if the acquired businesses fail to generate expected synergies, the goodwill could be impaired, potentially eroding equity. The $6.2B goodwill is a key risk factor that investors should monitor closely.

The equity section reveals a company that is being capitalized through massive equity infusions rather than organic earnings. Retained earnings have been consistently negative and worsening, from -$1.8M in 2024Q1 to -$761M in 2026Q2, reflecting the operating losses during the transition. The $10.4B equity is therefore a product of shareholder contributions, not accumulated profits. This suggests that the company's ability to sustain its growth without further dilution is uncertain, and investors should be aware that future equity raises may be necessary to fund ongoing losses and acquisitions.

Despite the heavy acquisition activity, the company maintains a strong liquidity position with a current ratio of 4.11 and cash of $2.8B. This provides ample cushion for working capital needs and potential integration costs. However, the cash balance has been drawn down from $5.1B in 2025Q1, indicating that the company is actively deploying its capital. The high current ratio also suggests that the company may be holding excess cash or that its current liabilities are not yet reflective of the full scale of operations. As the roll-up continues, liquidity could tighten if cash is deployed faster than it is replenished, but for now, the balance sheet appears well-positioned to weather short-term shocks.